User profiles for Venice Servellita
 | Venice ServellitaUniversity of California San Francisco Verified email at ucsf.edu Cited by 5123 |
[PDF][PDF] Emergence and rapid transmission of SARS-CoV-2 B. 1.1. 7 in the United States
The highly transmissible B.1.1.7 variant of SARS-CoV-2, first identified in the United Kingdom,
has gained a foothold across the world. Using S gene target failure (SGTF) and SARS-CoV…
has gained a foothold across the world. Using S gene target failure (SGTF) and SARS-CoV…
[PDF][PDF] Neutralizing immunity in vaccine breakthrough infections from the SARS-CoV-2 Omicron and Delta variants
V Servellita, AM Syed, MK Morris, N Brazer, P Saldhi… - Cell, 2022 - cell.com
Virus-like particle (VLP) and live virus assays were used to investigate neutralizing immunity
against Delta and Omicron SARS-CoV-2 variants in 259 samples from 128 vaccinated …
against Delta and Omicron SARS-CoV-2 variants in 259 samples from 128 vaccinated …
[HTML][HTML] CRISPR–Cas12-based detection of SARS-CoV-2
…, X Deng, G Yu, CL Fasching, V Servellita… - Nature …, 2020 - nature.com
An outbreak of betacoronavirus severe acute respiratory syndrome (SARS)-CoV-2 began in
Wuhan, China in December 2019. COVID-19, the disease associated with SARS-CoV-2 …
Wuhan, China in December 2019. COVID-19, the disease associated with SARS-CoV-2 …
[PDF][PDF] Longitudinal comparison of the developing gut virome in infants and their mothers
…, T Haggerty, A Sotomayor-Gonzalez, V Servellita… - Cell host & …, 2023 - cell.com
The human gut virome and its early life development are poorly understood. Prior studies
have captured single-point assessments with the evolution of the infant virome remaining …
have captured single-point assessments with the evolution of the infant virome remaining …
[PDF][PDF] Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant
We identified an emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
variant by viral whole-genome sequencing of 2,172 nasal/nasopharyngeal swab samples …
variant by viral whole-genome sequencing of 2,172 nasal/nasopharyngeal swab samples …
[HTML][HTML] Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination
…, A Sotomayor-Gonzalez, V Servellita… - Nature, 2022 - nature.com
SARS-CoV-2 Delta and Omicron are globally relevant variants of concern. Although individuals
infected with Delta are at risk of developing severe lung disease, infection with Omicron …
infected with Delta are at risk of developing severe lung disease, infection with Omicron …
[HTML][HTML] Transmission, infectivity, and antibody neutralization of an emerging SARS-CoV-2 variant in California carrying a L452R spike protein mutation
We identified a novel SARS-CoV-2 variant by viral whole-genome sequencing of 2,172
nasal/nasopharyngeal swab samples from 44 counties in California. Named B. 1.427/B. 1.429 to …
nasal/nasopharyngeal swab samples from 44 counties in California. Named B. 1.427/B. 1.429 to …
[HTML][HTML] Adeno-associated virus type 2 in US children with acute severe hepatitis
V Servellita, A Sotomayor Gonzalez, DM Lamson… - Nature, 2023 - nature.com
As of August 2022, clusters of acute severe hepatitis of unknown aetiology in children have
been reported from 35 countries, including the USA 1 , 2 . Previous studies have found …
been reported from 35 countries, including the USA 1 , 2 . Previous studies have found …
[HTML][HTML] Shotgun transcriptome, spatial omics, and isothermal profiling of SARS-CoV-2 infection reveals unique host responses, viral diversification, and drug …
In less than nine months, the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
killed over a million people, including >25,000 in New York City (NYC) alone. The …
killed over a million people, including >25,000 in New York City (NYC) alone. The …
[HTML][HTML] SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood
…, SK Pillai, A Sotomayor-Gonzalez, V Servellita… - Nature …, 2020 - nature.com
Given the limited availability of serological testing to date, the seroprevalence of SARS-CoV-2-specific
antibodies in different populations has remained unclear. Here, we report very …
antibodies in different populations has remained unclear. Here, we report very …
